about us



Cellmedi is an internationally recognized high-tech enterprise specializing in cell therapy and regenerative medicine development. The company has established two subsidiaries: Shanxi Cell Therapy Technology Group and Shanxi Cell Resource Bank, with headquarters locate within Shanxi Ren’an Hospital.
The company focuses on the processing and storage of human cells, and the research, development, and application of regenerative medicine.
Cellmedi focuses on preventing and treating a wide range of illnesses and conditions include: Neurodegenerative diseases, cardiovascular diseases, Diabetes, bone and joint disorders, autoimmune diseases, Blood disorders and cancers.


The company is led by prominent scientists, including Dr. Huidong Jia, director of regenerative medicine research center, former Senior Research Fellow at the University of Oxford’s Institute of Biomedical Engineering, and Dr. Yuan Jia. In collaboration with the National Center for Human Genome Research (Northern China), the company has invested in establishing China’s first clinical-grade joint workstation. This workstation is a pioneering initiative in the biomedical industry, integrating Nobel laureates, academicians, and clinical experts into a cohesive team. It is the first enterprise to incorporate cell collection, processing, storage, manufacture, and research as well as clinical therapy within a hospital setting, offering a fully integrated industrial chain.



Leading the Way in

Center for Cellular Medicine

Empowering patients with cutting-edge regenerative medical treatments and premier healthcare options.

Our Story

The Evolution of Cellmedi

At Cellmedi, we are dedicated to connecting individuals with top-tier stem cell treatments, revolutionizing healthcare access.

Our Story

Cellmedi

Vision

To become a global outstanding enterprise in the field of life sciences

Mission

Leading life science & technology to serve human healthcare

Culture

Sincere         kindness           excellent



Partners

Institute of Biomedical Engineering,
University of Oxford, United Kingdom

The Department of Biomedical Engi- neering at the University of Oxford is a top academic center for medical inno- vation in the UK . It has won the Queen’s Anniversary Prize and has ex tensive experience in clinical research.
The Medical and Health Information Computing Laboratory under the Department of Biomedical Engineering is committed to conducting arti cial intelligence research in the eld of clin- ical and health information. The labora- tory has the authorization of the world’s largest anonymous medical database, insists on clinical cooperation as the core, and ensures that the research results can be directly used to improve the quality of medical services.

Roslin Institute, University of Edinburgh, United Kingdom

The Roslin Institute was established in 1993. It was formerly the Institute of Animal Genetics of the University of Edinburgh, which was established in 1919. It cultivated the world’s rst cloned animal, Dolly the sheep. Dolly the sheep is a new individual cultivated from adult somatic cells of mammals using cell nuclear transplantation tech- nology. The Roslin Institute is the world’s earliest and most fruitful outstanding research institution in the development of stem cell nuclear trans- plantation technology. The University of Edinburgh was founded in 1583, and biomedicine is the university’s global advantage discipline.

National Human Genome North-ern Research Center (CHGB)

Digital Marketing Shanxi Bioengineering Society Stem Cell and Biological Immunotherapy

Fresenius Kabi Expert Resource Library

Technical Reserves

“Nobel Prize” academician expert technology transformation platform

Share some details here for Service one. This is a flexible section where you can share anything you want. It could be details or some information about your service. Specific immune cell therapy for tumors, gene editing and drug carrier technology, new generation of small molecule targeted anti-tumor drugs, blood lipid purification and component removal technology, genetic diagnosis technology, intestinal micro-ecological restoration technology, stem cell and biological derivatives producing technology.

Cell therapy and genetic testing diagnostic platform

 1. Cell therapy technology,
 2. Cell health and anti-aging technology,
3. Genetic testing/diagnostic technology,
4. Cell processing and storage technology,

Laboratory

International Biomedical Joint Innovation and Transformation Base, a Trinity of R&D, Production and Transformationes Empower Your Brand

01

Cell therapy technology research and development

Joint Laboratory of International Biomedical Experts

GMP laboratory A+B level, used for the production of clinical-grade cell therapy products.
C+D level laboratories are used for scientific research-level cell culture and related research.
The conventional laboratory is 100,000 level and is used for conventional experimental research.

02

Cell production
and storage


Clinical-grade cell production repository


Clinical grade cell therapy product production laboratory and clinical-grade cell and tissue resource storage library.

03

Technology SolutionsCell therapy technology
clinical
transformation

Clinical Transformation Center of Cellular Prevention and Treatment Technology Gene Testing and Diagnosis Center of Shanxi Ren’an Hospital Health Care Center.

Transform Your Health With Cellmedi Today

Our Promise

International Biomedical Joint Innovation and Transformation Base, a Trinity of R&D, Production and Transformation

Cell therapy technology research and development

Joint Laboratory of International Biomedical Experts


GMP laboratory A+B level, used for the production of clinical-grade cell therapy products.
C+D level laboratories are used for scientific research-level cell culture and related research.
The conventional laboratory is 100,000 level and is used for conventional experimental research.

Cell production and storage

Clinical-grade cell production repository


Clinical-grade cell therapy product production laboratory and clinical-grade cell and tissue resource storage library.

Cell therapy technology transformation





Clinical Transformation Center
of Cellular Prevention and Treatment
Technology Gene Testing
and Diagnosis Center of Shanxi
Ren’an Hospital Health Care
Center.

Client Stories

What Our Clients Say

Cellmedi provided the best medical assistance I have ever received. Their care and expertise are unmatched.My name is Wu , and I live in Hong Kong. Due to the pressures of work and daily life, I often felt physically weak over the past few years and became particularly prone to catching colds. On a friend’s recommendation, I learned about Cellmedi, and after several consultations, I decided to go to Taiyuan, Shanxi, on May 10, 2022, for stem cell immunity-boosting treatment.
I was extremely satisfied with the entire cell therapy process! The hospital was very responsive, and from initial consultation to scheduling treatment, everything went smoothly with a straightforward and efficient process that minimized waiting time. The doctor’s expertise was evident; they designed a precise treatment plan for me, and the results were impressive. The cost was very reasonable, especially for such a high-end treatment—it was truly excellent value for money. The medical environment was clean and comforting, and the staff provided attentive and thorough service, always ready to answer my questions, which made me feel well cared for. Additionally, the hospital’s equipment was top-notch, with comprehensive facilities that instilled confidence.
After just one immune stem cell transfusion, I didn’t catch a cold that winter, which was nothing short of a miracle for someone like me who normally relied on ginseng daily throughout the season. I’m grateful and am planning to continue this stem cell immune treatment yearly.

-John Wu

My name is Shan XX, and I currently live in Europe, while my parents still reside in China. My father has had arthritis for some time, and as he’s gotten older, his knee problems have worsened to the point where he can barely walk. We conducted extensive research on treatment options from abroad, hoping to find an effective solution. When we discovered through a WeChat article that stem cell therapy could greatly improve or even cure this condition, we explored several major hospitals and ultimately chose Cellmedi for its outstanding value and high-quality care. Since my parents live in Zhejiang, we were initially concerned about his comfort and convenience in Taiyuan.
I must express my heartfelt thanks to the Cellmedi Center for the exceptional service they provided. From the start, their concierge met us at the high-speed rail station, providing professional support throughout our entire stay. We were deeply touched by the warm and attentive service, especially as they patiently explained every step of the process, from initial check-ups to the expert team’s personalized treatment plan, and finally to the comprehensive post-treatment evaluation. Every detail was managed so smoothly that it reassured us and gave us complete confidence in the treatment process.
Our stay at the five-star hotel was both comfortable and cozy, offering a perfect space to rest between treatments. The center thoughtfully arranged a cultural tour of Shanxi during our free time, which allowed us to relax and recharge. Visiting the UNESCO World Heritage site, Mount Wutai, and experiencing its profound Buddhist culture was incredibly comforting and uplifting, calming our minds and soothing our anxieties.
We are immensely grateful to the Cellmedi Center for their professionalism and care. This experience was more than a medical treatment; it was a journey of healing for both body and soul. We are committed to following through with the recommended treatment plan, and we hold great hope for my father’s full recovery. He even hopes one day to walk up Mount Wutai on his own to fulfill a promise of gratitude.I found hope and healing through Cellmedi’s advanced treatments. Truly life-changing medical care.

-Alex shan

I am a 55-year-old teacher from Datong, Shanxi Province, with a 10-year history of managing diabetes. Initially, I relied on medication to control my blood sugar, but as my condition worsened, I had to start administering insulin myself.
In the beginning, my symptoms were typical—dry mouth and frequent urination. However, over time, I started experiencing vision issues and heart discomfort, which made me increasingly anxious about my health and uncertain how to stop this downward spiral. Eventually, through a recommendation from my local doctor, I came to Taiyuan with a hopeful but cautious mindset.
Dr. Jia at Cellmedi offered me a stem cell treatment plan aimed at improving insulin resistance and stabilizing blood sugar levels. This approach helps maintain consistent blood sugar control and delays the progression of diabetic complications.
Before starting the stem cell therapy, my routine was one injection of long-acting insulin (10 units) each night and a short-acting insulin injection (10 units) before lunch, with my post-meal blood sugar fluctuating between 9 and 10 mmol/L. After the first round of treatment, my post-meal blood sugar dropped to around 7–8 mmol/L. By the second round and into the third, it stabilized even further, maintaining between 5.5 and 6.5 mmol/L.
As my treatment progressed, I’ve been able to reduce my medication, and my complications have gradually lessened. I feel a renewed sense of hope and have become more optimistic. I’m committed to completing all four treatment rounds, along with incorporating regular exercise and a healthy diet, as I work towards living a life as close to normal as possible.

-miss Ding

My name is Wang XX, a 62-year-old woman. In 2022, I began experiencing frequent, unexplained bleeding from my nose and mouth. After a hospital visit, I was diagnosed with acute myeloid leukemia, a diagnosis that threw my family and me into a state of shock. I could never have imagined facing such a severe illness, especially as I had been looking forward to a peaceful retirement, spending time with my family, and traveling with my husband. Suddenly, all our plans were disrupted, and instead of helping others, I found myself needing care.
Later, my children researched and found Cellmedi. They believed that recent advancements in cell therapy offered real potential, although I was initially skeptical and didn’t have many options.
Genetic testing showed mutations in three Class I genes with high mutation rates. When we arrived in Taiyuan, Dr. Jia conducted a comprehensive examination and proposed a detailed treatment plan. I was surprised to find the treatment costs well within my expectations, which gave me the confidence to proceed.
After nearly eight months of immune cell therapy, as of August 3, 2023, the mutations in all three Class I genes had decreased to nearly zero, and my condition has been entirely controlled. Dr. Jia continues to follow up with me regularly, closely monitoring my progress. I feel as if I’ve regained my retirement years, and I am incredibly grateful and overjoyed to have my life back.

-wang bai yin

I am the Director of Radiology at a Class III hospital. In March 2018, I was diagnosed with pancreatic cancer at the Chinese PLA General Hospital and was discharged after initial treatment showed improvement.
 
In May, June, and July of the same year, I underwent CIK immunotherapy as a supplementary treatment at Cellmedi. This therapy brought my tumor marker CA19-9 levels down from 192 to 34, returning to the normal range.
 
Additionally, the discomfort I experienced from chemotherapy and radiotherapy subsided, I noticed regrowth of dark hair, regained energy, and my appetite and sleep returned to normal. My weight also increased from 63 kg to 66 kg. My health and overall quality of life have improved remarkably.

-DR.zhao

My name is Li XX, and I was diagnosed with stomach cancer that had metastasized to the liver.
On August 30, 2020, I visited Cellmedi for an initial consultation about cell therapy. By January 21, 2021, my condition had worsened significantly, with a liver tumor measuring 14*9*11 cm, and my overall health was poor.
On February 5, 2021, I received my first cell therapy treatment, followed by two additional rounds. This brought significant improvement—my baseline immunity was adjusted, and my physical condition improved markedly. By the follow-up on May 27, 2021, while the tumor size remained unchanged, the ascites had been significantly reduced.
After the fourth round of immune cell therapy, my baseline immunity improved, my general health continued to recover, and the large liver tumor was effectively controlled. My quality of life has greatly improved, allowing me to live a “tumor-bearing” life with stability.

-li chen

Service process description

Still have a question?

If you have any other queries, feel free to reach out to us.

Welcome to contact us  欢迎联系我们

Scroll to Top